Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37937763

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Nov 23
First author
Planchard D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Feb 1;390(5):478. doi: 10.1056/NEJMc2314600.
    note
    Source null
    related pmid
    38294983
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Feb 1;390(5):478-479. doi: 10.1056/NEJMc2314600.
    note
    Source null
    related pmid
    38294984
    relationship
    Comment in

Authors and identifiers

  1. name
    Planchard D
    type
    Author
  2. name
    Jänne PA
    type
    Author
  3. name
    Cheng Y
    type
    Author
  4. name
    Yang JC
    type
    Author
  5. name
    Yanagitani N
    type
    Author
  6. name
    Kim SW
    type
    Author
  7. name
    Sugawara S
    type
    Author
  8. name
    Yu Y
    type
    Author
  9. name
    Fan Y
    type
    Author
  10. name
    Geater SL
    type
    Author
  11. name
    Laktionov K
    type
    Author
  12. name
    Lee CK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Planchard D
    type
    Author
  2. name
    Jänne PA
    type
    Author
  3. name
    Cheng Y
    type
    Author
  4. name
    Yang JC
    type
    Author
  5. name
    Yanagitani N
    type
    Author
  6. name
    Kim SW
    type
    Author
  7. name
    Sugawara S
    type
    Author
  8. name
    Yu Y
    type
    Author
  9. name
    Fan Y
    type
    Author
  10. name
    Geater SL
    type
    Author
  11. name
    Laktionov K
    type
    Author
  12. name
    Lee CK
    type
    Author
bibliography ids
  1. nci-bib-895953ccab830d43c63c9c0b
book metadata
content sha256
91ef5af84c11925fcee0b0aa0ea78eba1ec674e1258538f16bd4e2eb0db253da
document type
citation
dois
  1. 10.1056/NEJMoa2306434
electronic publication date
display
2023 Nov 8
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37937763
immutable id
pubmed:37937763@91ef5af84c11925fcee0b0aa0ea78eba1ec674e1258538f16bd4e2eb0db253da
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
21
name
The New England journal of medicine
nlm unique id
0255562
pages
1935-1948
volume
389
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 Feb 1;390(5):478. doi: 10.1056/NEJMc2314600.
    note
    Source null
    related pmid
    38294983
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 Feb 1;390(5):478-479. doi: 10.1056/NEJMc2314600.
    note
    Source null
    related pmid
    38294984
    relationship
    Comment in
outcomes validated
false
pmid
37937763
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
e1e0fe1f93735336c341a1dcb04a6157b23ba06b71683bc519833d54286a158f
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2023 Nov 23
precision
day
year
2023
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37937763/
title
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.

Preserved source evidence · Not medical advice